Cargando…
Exosomal miRNA-146a is downregulated in clear cell renal cell carcinoma patients with severe immune-related adverse events
Here we report the results of the pilot project of exosomal miRNA expression levels in clear cell renal cell carcinoma (ccRCC) patients with different clinical response to ICIs (nivolumab) and treatment related toxicity. Immune-related adverse events (irAEs) are a major cause of immune checkpoint in...
Autores principales: | Ivanova, E., Asadullina, D., Rakhimov, R., Izmailov, A., Izmailov, Al., Gilyazova, G., Galimov, Sh., Pavlov, V., Khusnutdinova, E., Gilyazova, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263420/ https://www.ncbi.nlm.nih.gov/pubmed/35846077 http://dx.doi.org/10.1016/j.ncrna.2022.06.004 |
Ejemplares similares
-
Exosomal MicroRNA Levels Associated with Immune Checkpoint Inhibitor Therapy in Clear Cell Renal Cell Carcinoma
por: Ivanova, Elizaveta, et al.
Publicado: (2023) -
Exosomal miRNA-155 and miRNA-146a are promising prognostic biomarkers of the severity of hemorrhagic fever with renal syndrome
por: Gilyazova, Irina, et al.
Publicado: (2022) -
MicroRNA Expression Signatures in Clear Cell Renal Cell Carcinoma: High-Throughput Searching for Key miRNA Markers in Patients from the Volga-Ural Region of Eurasian Continent
por: Gilyazova, Irina, et al.
Publicado: (2023) -
MiRNA-146a—A Key Player in Immunity and Diseases
por: Gilyazova, Irina, et al.
Publicado: (2023) -
MicroRNA Processing Pathway-Based Polygenic Score for Clear Cell Renal Cell Carcinoma in the Volga-Ural Region Populations of Eurasian Continent
por: Ivanova, Elizaveta, et al.
Publicado: (2022)